ISpecimen Company Insiders
ISPC Stock | USD 1.07 0.05 4.46% |
ISpecimen's insiders are aggressively buying. The analysis of the overall insider sentiment regarding iSpecimen suggests that all insiders are extremely bullish. ISpecimen employs about 24 people. The company is managed by 15 executives with a total tenure of roughly 56 years, averaging almost 3.0 years of service per executive, having 1.6 employees per reported executive.
Insider Sentiment 100
Aggressively Buying
Selling | Buying |
Latest Trades
2023-09-14 | Benjamin Bielak | Acquired 18000 @ 0.72 | View | ||
2023-05-31 | Tracy Curley | Acquired 4400 @ 1.25 | View |
Monitoring ISpecimen's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
ISpecimen | Build AI portfolio with ISpecimen Stock |
ISpecimen Management Team Effectiveness
The company has return on total asset (ROA) of (0.734) % which means that it has lost $0.734 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.6537) %, meaning that it created substantial loss on money invested by shareholders. ISpecimen's management efficiency ratios could be used to measure how well ISpecimen manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -2.95. The current year's Return On Capital Employed is expected to grow to -3.38. At present, ISpecimen's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 301 K, whereas Non Current Assets Total are forecasted to decline to about 4.4 M.The current year's Common Stock Shares Outstanding is expected to grow to about 746.4 K, whereas Net Loss is forecasted to decline to (9.7 M).
ISpecimen Workforce Comparison
iSpecimen is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 649. ISpecimen holds roughly 24.0 in number of employees claiming about 4% of equities under Health Care industry.
ISpecimen Profit Margins
The company has Profit Margin (PM) of (1.4) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.55) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.55.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.56 | 0.4293 |
|
|
ISpecimen Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ISpecimen insiders, such as employees or executives, is commonly permitted as long as it does not rely on ISpecimen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ISpecimen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Brooks John L. Iii over a week ago Acquisition by Brooks John L. Iii of 125 shares of ISpecimen subject to Rule 16b-3 | ||
Jill Mullan over a month ago Disposition of 66637 shares by Jill Mullan of ISpecimen subject to Rule 16b-3 | ||
Yuying Liang over two months ago Insider Trading | ||
Jill Mullan over three months ago Disposition of 3099 shares by Jill Mullan of ISpecimen at 1.0 subject to Rule 16b-3 | ||
Ianelli Christopher over three months ago Disposition of 18229 shares by Ianelli Christopher of ISpecimen subject to Rule 16b-3 | ||
Obf Investments, Llc over three months ago Acquisition by Obf Investments, Llc of 307 shares of ISpecimen subject to Rule 16b-3 | ||
Obf Investments, Llc over three months ago Acquisition by Obf Investments, Llc of 119035 shares of ISpecimen at 666603.0 subject to Rule 16b-3 | ||
Ross Andrew L. over six months ago Acquisition by Ross Andrew L. of 10000 shares of ISpecimen at 1.41 subject to Rule 16b-3 |
ISpecimen Notable Stakeholders
An ISpecimen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ISpecimen often face trade-offs trying to please all of them. ISpecimen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ISpecimen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robert Lim | Treasurer, CEO | Profile | |
Katharyn Field | President | Profile | |
Emily Hubbard | VP Devel | Profile | |
Benjamin Bielak | Chief Secretary | Profile | |
Eric Langlois | Chief Officer | Profile | |
Dawn Michelle | VP Operations | Profile | |
Yuying Liang | Chief Officer | Profile | |
Annette Arnold | Vice Development | Profile | |
Tracy Curley | Treasurer CFO | Profile | |
Brielan Smiechowski | Senior Development | Profile | |
Carly Lejnieks | Vice Marketing | Profile | |
Leslie Hoyt | Senior Operations | Profile | |
Jill Mullan | S Director | Profile | |
David MD | Chief Officer | Profile | |
Evan Cox | Senior Innovation | Profile |
About ISpecimen Management Performance
The success or failure of an entity such as iSpecimen often depends on how effective the management is. ISpecimen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ISpecimen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ISpecimen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (3.11) | (2.95) | |
Return On Capital Employed | (3.56) | (3.38) | |
Return On Assets | (1.34) | (1.40) | |
Return On Equity | (3.77) | (3.59) |
Please note, the presentation of ISpecimen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ISpecimen's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ISpecimen's management manipulating its earnings.
ISpecimen Workforce Analysis
Traditionally, organizations such as ISpecimen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ISpecimen within its industry.ISpecimen Manpower Efficiency
Return on ISpecimen Manpower
Revenue Per Employee | 387.1K | |
Revenue Per Executive | 619.4K | |
Net Loss Per Employee | 520.7K | |
Net Loss Per Executive | 833.2K |
Complementary Tools for ISpecimen Stock analysis
When running ISpecimen's price analysis, check to measure ISpecimen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISpecimen is operating at the current time. Most of ISpecimen's value examination focuses on studying past and present price action to predict the probability of ISpecimen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISpecimen's price. Additionally, you may evaluate how the addition of ISpecimen to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |